SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-11-287409
Filing Date
2011-10-31
Accepted
2011-10-31 09:29:34
Documents
2
Group Members
QVT ASSOCIATES GP LLCQVT FINANCIAL GP LLCQVT FUND LP

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO SCHEDULE 13D d250625dsc13da.htm SC 13D/A 86691
2 AGREEMENT OF JOINT FILING d250625dex1.htm EX-1 13714
  Complete submission text file 0001193125-11-287409.txt   101982
Mailing Address 5871 OBERLIN DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 5871 OBERLIN DRIVE, SUITE 200 SAN DIEGO CA 92121 8585303600
ANADYS PHARMACEUTICALS INC (Subject) CIK: 0001128495 (see all company filings)

IRS No.: 223193172 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-79854 | Film No.: 111166803
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1177 AVENUE OF THE AMERICAS 9TH FLOOR NEW YORK NY 10036
Business Address 1177 AVENUE OF THE AMERICAS 9TH FLOOR NEW YORK NY 10036 212-705-8800
QVT Financial LP (Filed by) CIK: 0001290162 (see all company filings)

IRS No.: 113694008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A